Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
July 1, 1993
Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women
M Filicori, C Flamigni, G Cognigni, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1994
Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles
M Filicori, C Flamigni, P Dellai, et al.
Fertility and Sterility
|
April 9, 1998
Subcutaneous administration of a depot gonadotropin-releasing hormone agonist induces profound reproductive axis suppression in women
M Filicori, G E Cognigni, R Arnone, et al.
Human Reproduction (Oxford, England)
|
November 1, 1993
Role of gonadotrophin releasing hormone secretory dynamics in the control of the human menstrual cycle
M Filicori, G Cognigni, P Dellai, et al.
Acta Psychiatrica Scandinavica
|
January 10, 2002
Psychological consequences of the 1998 landslide in Sarno, Italy: a community study
F Catapano, R Malafronte, F Lepre, et al.
Fertility and Sterility
|
February 1, 1996
Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis
M Filicori, C Flamigni, G E Cognigni, et al.
Human Reproduction (Oxford, England)
|
November 1, 1996
Role of different GnRH agonist regimens in pituitary suppression and the outcome of controlled ovarian hyperstimulation
M Filicori, G E Cognigni, R Arnone, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
April 1, 1996
Is multiple pregnancy an unavoidable complication of ovulation induction? The case for pulsatile GnRH
M Filicori, G E Cognigni, R Arnone, et al.
Cell Death Discovery
|
February 3, 2017
Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-<i>κ</i>B signaling by degrading TRAF2-associated cIAP1 in cancer cells
Y Mitsuuchi, C A Benetatos, Y Deng, et al.
Plos One
|
July 12, 2013
Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions
Alastair J King, Marc R Arnone, Maureen R Bleam, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
The Journal of Clinical Endocrinology and Metabolism
|
July 1, 1993
Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women
M Filicori, C Flamigni, G Cognigni, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1994
Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles
M Filicori, C Flamigni, P Dellai, et al.
Fertility and Sterility
|
April 9, 1998
Subcutaneous administration of a depot gonadotropin-releasing hormone agonist induces profound reproductive axis suppression in women
M Filicori, G E Cognigni, R Arnone, et al.
Human Reproduction (Oxford, England)
|
November 1, 1993
Role of gonadotrophin releasing hormone secretory dynamics in the control of the human menstrual cycle
M Filicori, G Cognigni, P Dellai, et al.
Acta Psychiatrica Scandinavica
|
January 10, 2002
Psychological consequences of the 1998 landslide in Sarno, Italy: a community study
F Catapano, R Malafronte, F Lepre, et al.
Fertility and Sterility
|
February 1, 1996
Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis
M Filicori, C Flamigni, G E Cognigni, et al.
Human Reproduction (Oxford, England)
|
November 1, 1996
Role of different GnRH agonist regimens in pituitary suppression and the outcome of controlled ovarian hyperstimulation
M Filicori, G E Cognigni, R Arnone, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
April 1, 1996
Is multiple pregnancy an unavoidable complication of ovulation induction? The case for pulsatile GnRH
M Filicori, G E Cognigni, R Arnone, et al.
Cell Death Discovery
|
February 3, 2017
Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-<i>κ</i>B signaling by degrading TRAF2-associated cIAP1 in cancer cells
Y Mitsuuchi, C A Benetatos, Y Deng, et al.
Plos One
|
July 12, 2013
Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions
Alastair J King, Marc R Arnone, Maureen R Bleam, et al.
Page
of 3